Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Eurofins Central Laboratory history
Eurofins Central Laboratory company history timeline
By 1991, Eurofins's sales had risen to EUR 1.4 million.
In 1997, the company made its first acquisition, buying up Nutrition International and Product Safety Labs in the United States.
Eurofins boosted its U.K. presence in 1998, adding three more companies that were subsequently merged into its existing subsidiary to form Eurofins Scientific Ltd.
Similarly, in 1999, Eurofins acquired the Alpha Chemical and Biomedical Laboratories, based in California, adding its capacity for analyzing botanicals and nutraceuticals.
By the end of 2000, the company's acquisitions included Celab AG in Switzerland and Gesellschaft für Arbeitsplatz- und Umweltanalytik (GfA) mbH, operating in Munster, Germany, and Orleans, France.
Pinaud, Olivier, "'Nous sommes optimistes pour la suite de l'année.'" Investir, August 29, 2001.
New food tracking regulations encouraged the group to gain expertise in DNA sequencing and genotyping, in part through the acquisition of majority control of Germany's Medigenomix in 2001.
2001: The company launches GMO Platinum Assay for detecting the presence of genetically modified (GMO) food components.
The company had also begun developing an outsourcing arm, taking over the research, testing, and analysis operations for third parties, including a nutritional assay outsourcing agreement with Glon Sanders reached in 2002.
2003: The company acquires Genescan, with laboratories in Germany, United States, Hong Kong, and Brazil.
2005: The company acquires 25 percent of MWG-Biotech Ag in Germany.
For example, Eurofins was the very first international laboratory group to offer bird flu virus (H5N1) testing in food in 2005.
By 2008, the Group had grown to over 8,000 staff, and more than 150 laboratories in 29 countries.
In 2012, the Group celebrated 15 years since its IPO and this milestone coincided with achieving its ambition of becoming a billion euro annual revenue business, one year before its objective.
Eurofins used these funds in a focused manner and only raised equity again more than 15 years later in 2016 when its revenues already exceeded EUR 2 billion.
An operational goal was also set to develop the laboratory and IT infrastructure of a global leader in Testing for Life by 2020.
With the goal of continuously strengthening its leading positions in its chosen end markets, the Group formulated a 5-year growth plan with the objective to double in size again within 5 years and achieve 4bn annual revenues by 2020 through a mix of organic growth and acquisitions.
Over €6.7 billion in annualised revenues in 2021
By 2022, the Group has grown to 58,000 staff across a network of 900 laboratories in 54 countries, offering a portfolio of over 200,000 analytical methods.
Beyond 2022, thanks to the unique and best in class laboratory infrastructure established in Europe and North America and technological portfolio developed during previous years, Eurofins is looking to the future.
Rate Eurofins Central Laboratory's efforts to communicate its history to employees.
Eurofins Central Laboratory jobs
Do you work at Eurofins Central Laboratory?
Is Eurofins Central Laboratory's vision a big part of strategic planning?
Eurofins Central Laboratory competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Eurofins | - | $4.9B | 48,000 | 471 |
| Avanti Polar Lipids | 1969 | $37.5M | 100 | - |
| Tedor Pharma | 2001 | $11.0M | 20 | - |
| LLS Health CDMO | 1991 | $910,000 | 1 | - |
| Eon Labs, Inc. | - | - | 531 | - |
| Ascend Laboratories | - | $4.7M | 56 | - |
| Silliker, Inc. | 1967 | $120.0M | 635 | - |
| Frontage Laboratories | 2001 | $560,000 | 50 | 166 |
| Sovereign Pharmaceuticals | 1990 | $52.7M | 100 | - |
| Novel Laboratories | 2006 | $75.0M | 93 | - |
Eurofins Central Laboratory history FAQs
Zippia gives an in-depth look into the details of Eurofins Central Laboratory, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Eurofins Central Laboratory. The employee data is based on information from people who have self-reported their past or current employments at Eurofins Central Laboratory. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Eurofins Central Laboratory. The data presented on this page does not represent the view of Eurofins Central Laboratory and its employees or that of Zippia.
Eurofins Central Laboratory may also be known as or be related to Eurofins Central Laboratory and Eurofins Central Laboratory B.V.